Structure-based Drug Design is an Essential Tool for Quicker and More Cost-Efficient Lead Discovery

With the aid of artificial intelligence and AI-based sophisticated machine learning technology, data processing has become much easier, which greatly eases burdens for researchers,” said a senior scientist from Alfa Chemistry.

Cytiva opens Cell Culture Center of Excellence in Massachusetts

Supply of ISO 9001:2015 Certified Fluoropolymers to Step up Scientific Research

Recognized for their unmatched chemical and temperature resistance properties, fluoropolymer materials are widely used in many industries.

Emmes rapidly expands in India – driven by deep vaccines and infectious diseases expertise and enhanced study startup capabilities

BARDA supports development of novel AI/ML-based digital apps for visual and auditory symptomatic infectious disease detection

I wanted to share news of BARDA launching the “Digital Medical Countermeasures” program to develop digital solutions with VisualDx and Virufy to aid in infectious disease detection and pandemic preparedness.  With this partnership, VisualDx is creating an app that leverages AI/ML-based image analysis and questionnaires to analyze skin lesions and identify pox-based viruses (monkeypox, smallpox, etc.), and can be modified for future outbreaks. The app will inform users about their skin conditions in real-time to streamline appropriate care and treatment options.

Rho Appoints Clinical Oncologist and Industry Veteran J. Marc Pipas, MD, As Senior Medical Director

Dr. Pipas’ Experience Enhances Rho’s Oncology Capabilities

Inizio expands senior leadership team with key appointment

AbsoluteCare Selects ZeOmega for Chronic Care Management for High-Risk Patient Populations

ZeOmega Helps Healthcare Provider Reach and Manage Critically Ill Patients

Quanticate announces plans to accelerate growth in North America

Lifeasible Released a Platform Based on High-throughput Plant Phenotyping

COFEPRIS Certifies 5 CTL Amedica Devices for Commercialization, Marketing in Mexico

CTL Amedica Corporation has received official certification from COFEPRIS, the agency charged with overseeing the quality of medical devices and products made in and imported into Mexico, to commercialize and market the Valeo II silicon nitride interbody product line in Mexico. The Valeo II interbody devices are made entirely of silicon nitride, which demonstrates a superior osteogenic response for enhanced fusion, promotes unique anti-bacterial properties and provides comprehensive imaging across all modalities. CTL Amedica is the world’s exclusive provider of silicon nitride spine products, and the certification includes 5 silicon nitride devices.

Matexcel Enlarged Its Offerings for Co-based Metal Powder Products

Creative BioMart Provides MHC Solutions for Cell Therapy & Vaccine Development

Profacgen Updated Its In Silico Protein-protein Interactions Prediction Service

RCH Solutions To Present at 20/15 Visioneers’ Virtual Cloud Lab, HTE and Lab Automation Conference

Leading a talk on Next Generation Compute Environments, the long-time provider of computing consulting and execution services exclusively to R&D teams in the Life Sciences will take the virtual stage on November 8, 2022.

Full-Scale PROTAC In Vivo Evaluation Services to Facilitate PROTAC Drug R&D

BOC Sciences can take care of the PROTAC in vivo evaluation workload for clients with a transparent project process and comprehensive evaluation reports to facilitate PROTAC discovery and development programs prior to clinical trials.

Synthetic Biology Platform: Meet All Synthetic Biology Demands in One Place

The Synthetic Biology Platform is designed to program comprehensive biosynthesis development in one place.

New tool to identify patients at high risk of Kidney Dysfunction presented at American Society of Nephrology Conference

A new tool has been developed to identify those diabetes patients who are at risk of developing Chronic Kidney Disease. Early diagnosis can lead to earlier treatment and save lives.

CD ComputaBio Introduces Four Docking Software for Drug Development

Pronalyse Supports Drug Discovery with the Launch of Biosimilar Analysis Solutions